dr. george on investigational agents downstream of the androgen receptor in prostate cancer
Published 4 years ago • 77 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
2:07
dr. george on the changing treatment landscape in prostate cancer
-
8:28
metastatic prostate cancer: androgen receptor biology
-
1:42
dr. george on results of abi race trial in prostate cancer
-
1:24
dr. george on sequential therapy in metastatic prostate cancer
-
0:29
copy of dr. george on sequential therapy in metastatic prostate cancer
-
1:05
dr. agarwal on androgen receptor inhibitors for prostate cancer
-
13:04
androgen receptor-targeted ttherapies in advanced prostate cancer
-
12:48
micro ultrasound and mri of the prostate
-
2:01
dr ravi on the investigation of rcb following arpi treatment in high-risk prostate cancer
-
1:31
dr. higano on the toxicity of androgen receptor inhibitors in crpc
-
0:58
sabizabulin in men with mcrpc who progressed on an androgen receptor targeting agent
-
1:32
suzanne a. w. fuqua, phd, discusses the androgen receptor in breast cancer
-
6:01
androgen receptor and castration-resistant prostate cancer
-
1:23
dr. morris on safety profiles of ar inhibitors in prostate cancer
-
1:41
future developments in the treatment of prostate cancer
-
6:14
androgen receptor splice variant, ar-v7, as prostate cancer biomarker
-
1:11
the management of prostate cancer with androgen receptors
-
1:00
dr. wise on ar-directed therapy for prostate cancer
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer